论文部分内容阅读
五十年代Clowes等人证实了采用透过薄膜氧合血液(简称膜氧合)的原理适用于临床。发展到现在,膜式氧合器(简称膜肺或EMCO)已成为心脏外科的可靠工具,并且已成为较长时间辅助呼吸的良好设备。特别是近十年来,应用膜式氧合器对呼吸衰竭的垂危病人进行治疗有了进展。大多数配备有现代呼吸监护设备,经专门训练的护士和医师小组,能够提供精细复杂的呼吸医疗护理(RCU),有选择地应用于垂危病人以维持生命。通过膜氧合来维持生命,为可逆性肺部损伤而造成严重缺氧的病人,提供气体交换和生理稳定,争取治疗所需要的时间,同时也可以减少因长期使用机械通气而造成的肺损伤或氧中毒等并发
In the 1950s, Clowes et al. Confirmed that the principle of using oxygenated blood through the membrane (referred to as membrane oxygenation) is suitable for clinical use. Nowadays, membrane oxygenators (Membrane lungs or EMCOs) have become a reliable tool for cardiac surgery and have become a good device for assisted breathing for longer periods of time. Especially in the past decade, the application of membrane oxygenator has made great progress in the treatment of patients with severe respiratory failure. Most are equipped with modern respiratory monitoring equipment, a team of specially trained nurses and physicians who are able to provide sophisticated complex respiratory medical care (RCU) that is selectively applied to critically ill patients for survival. Maintaining life through membrane oxygenation, providing patients with severe hypoxia for reversible lung injury, providing gas exchange and physiologic stability for the duration of treatment, and also reducing lung damage due to long-term mechanical ventilation Or oxygen poisoning and so on